Cargando…

Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway

Gut microbiota (GM) dysbiosis and bile acid (BA) metabolism disorder play an important role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Probiotics had a beneficial effect on NAFLD, but further study is needed to explore probiotics as a potential therapeutic agent to NAFLD. The a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Minmin, Yan, Junbin, Wu, Liyan, Wu, Jinting, Chen, Zheng, Jiang, Jianping, Chen, Zhiyun, He, Beihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387197/ https://www.ncbi.nlm.nih.gov/pubmed/34458376 http://dx.doi.org/10.1155/2021/2264737

Ejemplares similares

Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota
por: Yan, Junbin, et al.
Publicado: (2022)

The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases
por: Yan, Junbin, et al.
Publicado: (2021)

Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments
por: He, Beihui, et al.
Publicado: (2022)

Predicting Target Genes of San-Huang-Chai-Zhu Formula in Treating ANIT-Induced Acute Intrahepatic Cholestasis Rat Model via Bioinformatics Analysis Combined with Experimental Validation
por: Yao, Jiaming, et al.
Publicado: (2021)

The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice
por: He, Beihui, et al.
Publicado: (2017)

Natural Compounds: A Potential Treatment for Alcoholic Liver Disease?
por: Yan, Junbin, et al.
Publicado: (2021)

Chlorogenic Acid Inhibits Lipid Deposition by Regulating the Enterohepatic FXR-FGF15 Pathway
por: Ye, Xiaolin, et al.
Publicado: (2022)

Lonicera Caerulea Juice Alleviates Alcoholic Liver Disease by Regulating Intestinal Flora and the FXR-FGF15 Signaling Pathway
por: Zhang, Baixi, et al.
Publicado: (2023)

Minocycline-induced disruption of the intestinal FXR/FGF15 axis impairs osteogenesis in mice
por: Carson, Matthew D., et al.
Publicado: (2023)

Molecular Basis of Bile Acid-FXR-FGF15/19 Signaling Axis
por: Katafuchi, Takeshi, et al.
Publicado: (2022)

Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
por: Qiu, Yixuan, et al.
Publicado: (2021)

Prediction of VEGF-C as a Key Target of Pure Total Flavonoids From Citrus Against NAFLD in Mice via Network Pharmacology
por: Hong, Wei, et al.
Publicado: (2019)

Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid/FXR-FGF15 in rats
por: Sun, Hanxiang, et al.
Publicado: (2023)

Sodium cholate ameliorates nonalcoholic steatohepatitis by activation of FXR signaling
por: Pan, Linyu, et al.
Publicado: (2023)

Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress
por: Cai, Weijia, et al.
Publicado: (2023)

PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis
por: Zhou, Xueyan, et al.
Publicado: (2014)

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
por: Lu, Zengsheng, et al.
Publicado: (2020)

Repression of intestinal transporters and FXR-FGF15 signaling explains bile acids dysregulation in experimental colitis-associated colon cancer
por: Cao, Lijuan, et al.
Publicado: (2017)

Combined ASBT Inhibitor and FGF15 Treatment Improves Therapeutic Efficacy in Experimental Nonalcoholic Steatohepatitis
por: Matye, David J., et al.
Publicado: (2021)

Indole alkaloids of Alstonia scholaris (L.) R. Br. alleviated nonalcoholic fatty liver disease in mice fed with high-fat diet
por: Sun, Shui-Fen, et al.
Publicado: (2022)

Hepatic SIRT6 Modulates Transcriptional Activities of FXR to Alleviate Acetaminophen-induced Hepatotoxicity
por: Liu, Changhui, et al.
Publicado: (2022)

FGF15 promotes hepatic NPC1L1 degradation in lithogenic diet-fed mice
por: Mo, Pingfan, et al.
Publicado: (2022)

Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis
por: Byun, Sangwon, et al.
Publicado: (2018)

Targeting FXR and FGF19 to Treat Metabolic Diseases—Lessons Learned From Bariatric Surgery
por: Bozadjieva, Nadejda, et al.
Publicado: (2018)

Sesamolin Alleviates Nonalcoholic Fatty Liver Disease through Modulating Gut Microbiota and Metabolites in High-Fat and High-Fructose Diet-Fed Mice
por: Yu, Jing, et al.
Publicado: (2022)

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE(−/−)FXR(−/−) Mice
por: Lee, Yenna, et al.
Publicado: (2021)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
por: Ye, Xin, et al.
Publicado: (2022)

Metformin alleviates irradiation-induced intestinal injury by activation of FXR in intestinal epithelia
por: Yang, Jing-Yu, et al.
Publicado: (2022)

Activation of the bile acid receptors TGR5 and FXR in the spinal dorsal horn alleviates neuropathic pain
por: Wu, Yuning, et al.
Publicado: (2023)

Dendrobium officinale alleviates high-fat diet-induced nonalcoholic steatohepatitis by modulating gut microbiota
por: Tian, Gege, et al.
Publicado: (2023)

Selective targeting of nuclear receptor FXR by avermectin analogues with therapeutic effects on nonalcoholic fatty liver disease
por: Jin, Lihua, et al.
Publicado: (2015)

Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice
por: Patel, Satish, et al.
Publicado: (2022)

FXR activation promotes intestinal cholesterol excretion and attenuates hyperlipidemia in SR‐B1‐deficient mice fed a high‐fat and high‐cholesterol diet
por: Singh, Amar B., et al.
Publicado: (2020)

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis
por: Ye, Qingyan, et al.
Publicado: (2023)

Concurrent miR-21 suppression and FXR activation as a mechanism of improvement in nonalcoholic fatty liver disease
por: Mazzini, Guilherme S., et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
por: Chiu, Chien-Chao, et al.
Publicado: (2017)

Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice
por: Yang, Yan, et al.
Publicado: (2021)

Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress
por: Zhong, Yadi, et al.
Publicado: (2022)

Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice
por: Ding, Lili, et al.
Publicado: (2021)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ojnkktn96m65slragjcj16o268